212 related articles for article (PubMed ID: 25720243)
1. [Neurocognitive impairments of HIV infected individuals -- preliminary results of a national prevalence study in Hungary].
Lakatos B; Szabó Z; Bozzai B; Bánhegyi D; Gazdag G
Ideggyogy Sz; 2014 Nov; 67(11-12):409-14. PubMed ID: 25720243
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
[TBL] [Abstract][Full Text] [Related]
3. Effect of age and level of education on neurocognitive impairment in HIV positive Zambian adults.
Kabuba N; Menon JA; Franklin DR; Lydersen S; Heaton RK; Hestad KA
Neuropsychology; 2018 Jul; 32(5):519-528. PubMed ID: 29504779
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.
Lawler K; Mosepele M; Ratcliffe S; Seloilwe E; Steele K; Nthobatsang R; Steenhoff A
J Int AIDS Soc; 2010 Apr; 13():15. PubMed ID: 20406460
[TBL] [Abstract][Full Text] [Related]
5. Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe.
Nyamayaro P; Gouse H; Hakim J; Robbins RN; Chibanda D
BMC Infect Dis; 2020 May; 20(1):383. PubMed ID: 32471350
[TBL] [Abstract][Full Text] [Related]
6. Neurocognitive Impairment in the Combined Antiretroviral Therapy Era in a Romanian Cohort of Young Adults with Chronic HIV Infection.
Temereanca A; Ene L; Rosca A; Diaconu CC; Luca A; Burlacu R; Radoi R; Bulacu-Talnariu A; Marcotte TD; Achim CL; Ruta S
AIDS Res Hum Retroviruses; 2020 May; 36(5):367-372. PubMed ID: 31476875
[TBL] [Abstract][Full Text] [Related]
7. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients.
Ciccarelli N; Fabbiani M; Di Giambenedetto S; Fanti I; Baldonero E; Bracciale L; Tamburrini E; Cauda R; De Luca A; Silveri MC
Neurology; 2011 Apr; 76(16):1403-9. PubMed ID: 21502598
[TBL] [Abstract][Full Text] [Related]
8. Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients.
Grima P; Fabbiani M; Ciccarelli N; Tana M; Farina S; Colafigli M; Mondi A; Cauda R; Di Giambenedetto S
J Infect; 2012 Nov; 65(5):439-46. PubMed ID: 22863903
[TBL] [Abstract][Full Text] [Related]
9. Neurocognitive profile of HIV-positive adults on combined antiretroviral therapy: A single-centre study in Serbia.
Malagurski B; Bugarski Ignjatović V; Marić D; Nikolašević Ž; Mihić L; Brkić S
Appl Neuropsychol Adult; 2018; 25(6):513-522. PubMed ID: 28665215
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive Disorders in HIV-positive Patients.
Padole PS; Padhiyar RN; Yadav DS; Chavan SA
J Assoc Physicians India; 2023 Jun; 71(6):11-12. PubMed ID: 37355842
[TBL] [Abstract][Full Text] [Related]
11. Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia.
Ciccarelli N; Fabbiani M; Colafigli M; Trecarichi EM; Silveri MC; Cauda R; Murri R; De Luca A; Di Giambenedetto S
Antivir Ther; 2013; 18(2):153-60. PubMed ID: 23486721
[TBL] [Abstract][Full Text] [Related]
12. Factors related to HIV-associated neurocognitive impairment differ with age.
Fogel GB; Lamers SL; Levine AJ; Valdes-Sueiras M; McGrath MS; Shapshak P; Singer EJ
J Neurovirol; 2015 Feb; 21(1):56-65. PubMed ID: 25404233
[TBL] [Abstract][Full Text] [Related]
13. Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairment.
Anderson AM; Lennox JL; Nguyen ML; Waldrop-Valverde D; Tyor WR; Loring DW
J Neurovirol; 2016 Dec; 22(6):816-822. PubMed ID: 27245594
[TBL] [Abstract][Full Text] [Related]
14. Empiric neurocognitive performance profile discovery and interpretation in HIV infection.
Gomez D; Power C; Gill MJ; Koenig N; Vega R; Fujiwara E
J Neurovirol; 2019 Feb; 25(1):72-84. PubMed ID: 30519968
[TBL] [Abstract][Full Text] [Related]
15. Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy.
Garvey L; Surendrakumar V; Winston A
HIV Clin Trials; 2011; 12(6):333-8. PubMed ID: 22189152
[TBL] [Abstract][Full Text] [Related]
16. Correlations between computerized battery testing and a memory questionnaire for identification of neurocognitive impairment in HIV type 1-infected subjects on stable antiretroviral therapy.
Garvey LJ; Yerrakalva D; Winston A
AIDS Res Hum Retroviruses; 2009 Aug; 25(8):765-9. PubMed ID: 19678764
[TBL] [Abstract][Full Text] [Related]
17. Accelerated and accentuated neurocognitive aging in HIV infection.
Sheppard DP; Iudicello JE; Morgan EE; Kamat R; Clark LR; Avci G; Bondi MW; Woods SP;
J Neurovirol; 2017 Jun; 23(3):492-500. PubMed ID: 28321696
[TBL] [Abstract][Full Text] [Related]
18. Neurocognitive function profile in HIV-infected school-age children.
Koekkoek S; de Sonneville LM; Wolfs TF; Licht R; Geelen SP
Eur J Paediatr Neurol; 2008 Jul; 12(4):290-7. PubMed ID: 17950012
[TBL] [Abstract][Full Text] [Related]
19. Depression and neurocognitive performance in Portuguese patients infected with HIV.
Bragança M; Palha A
AIDS Behav; 2011 Nov; 15(8):1879-87. PubMed ID: 21598031
[TBL] [Abstract][Full Text] [Related]
20. Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong - a single center study.
Chan FCC; Chan P; Chan I; Chan A; Tang THC; Lam W; Fong WC; Lee MP; Li P; Chan GHF
BMC Infect Dis; 2019 Feb; 19(1):156. PubMed ID: 30760220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
